WhitTier Trust Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.28M Sell
31,384
-1,887
-6% -$249K 0.08% 177
2026
Q1
$4.66M Sell
33,271
-868
-3% -$122K 0.1% 159
2025
Q4
$4.14M Sell
34,139
-572
-2% -$69.5K 0.09% 174
2025
Q3
$3.91M Buy
34,711
+87
+0.3% +$9.89K 0.08% 174
2025
Q2
$3.84M Sell
34,624
-841
-2% -$89.5K 0.09% 183
2025
Q1
$3.97M Sell
35,465
-97
-0.3% -$10K 0.1% 173
2024
Q4
$3.28M Sell
35,562
-655
-2% -$59K 0.08% 188
2024
Q3
$3.04M Sell
36,217
-5,707
-14% -$435K 0.08% 195
2024
Q2
$2.88M Sell
41,924
-3,804
-8% -$254K 0.08% 186
2024
Q1
$3.35M Buy
45,728
+1,072
+2% +$82.4K 0.1% 177
2023
Q4
$3.62M Sell
44,656
-3,229
-7% -$251K 0.12% 161
2023
Q3
$3.59M Sell
47,885
-384
-0.8% -$29.5K 0.13% 156
2023
Q2
$3.72M Sell
48,269
-645
-1% -$51.4K 0.13% 153
2023
Q1
$4.06M Sell
48,914
-2,098
-4% -$174K 0.15% 137
2022
Q4
$4.38M Sell
51,012
-48
-0.1% -$3.8K 0.17% 131
2022
Q3
$3.15M Sell
51,060
-1,078
-2% -$68K 0.13% 153
2022
Q2
$3.22M Sell
52,138
-1,954
-4% -$121K 0.13% 150
2022
Q1
$3.22M Sell
54,092
-32,749
-38% -$2.09M 0.12% 158
2021
Q4
$6.31M Buy
86,841
+1,375
+2% +$94.7K 0.23% 103
2021
Q3
$5.97M Sell
85,466
-246
-0.3% -$17.3K 0.24% 101
2021
Q2
$5.9M Sell
85,712
-1,481
-2% -$98.9K 0.25% 98
2021
Q1
$5.64M Buy
87,193
+2,613
+3% +$168K 0.25% 98
2020
Q4
$4.93M Sell
84,580
-4,677
-5% -$282K 0.25% 98
2020
Q3
$5.64M Sell
89,257
-1,674
-2% -$116K 0.33% 75
2020
Q2
$7M Sell
90,931
-3,612
-4% -$277K 0.44% 61
2020
Q1
$7.07M Buy
94,543
+900
+1% +$62.2K 0.54% 50
2019
Q4
$6.08M Sell
93,643
-3,451
-4% -$225K 0.39% 70
2019
Q3
$6.15M Buy
97,094
+1,890
+2% +$124K 0.43% 62
2019
Q2
$6.43M Buy
95,204
+345
+0.4% +$22.7K 0.46% 61
2019
Q1
$6.17M Sell
94,859
-1,581
-2% -$105K 0.46% 60
2018
Q4
$6.03M Sell
96,440
-13,642
-12% -$954K 0.5% 58
2018
Q3
$8.5M Sell
110,082
-1,138
-1% -$85.9K 0.62% 46
2018
Q2
$7.88M Buy
111,220
+860
+0.8% +$60.7K 0.62% 45
2018
Q1
$8.32M Buy
110,360
+927
+0.8% +$73.7K 0.68% 39
2017
Q4
$7.84M Buy
109,433
+6,718
+7% +$510K 0.67% 43
2017
Q3
$8.32M Buy
102,715
+996
+1% +$76.2K 0.77% 33
2017
Q2
$7.2M Buy
101,719
+1,380
+1% +$91.8K 0.7% 40
2017
Q1
$6.82M Buy
100,339
+6,489
+7% +$456K 0.68% 40
2016
Q4
$6.72M Buy
93,850
+6,071
+7% +$451K 0.71% 39
2016
Q3
$6.95M Buy
87,779
+8,076
+10% +$656K 0.79% 35
2016
Q2
$6.65M Buy
79,703
+1,610
+2% +$143K 0.76% 39
2016
Q1
$7.17M Sell
78,093
-175
-0.2% -$15.8K 0.84% 34
2015
Q4
$7.92M Buy
78,268
+2,002
+3% +$208K 0.93% 23
2015
Q3
$7.49M Buy
76,266
+1,002
+1% +$111K 0.92% 25
2015
Q2
$8.81M Sell
75,264
-2,338
-3% -$255K 0.98% 23
2015
Q1
$7.62M Sell
77,602
-1,644
-2% -$167K 0.84% 27
2014
Q4
$7.47M Sell
79,246
-1,308
-2% -$135K 0.84% 29
2014
Q3
$8.57M Buy
80,554
+150
+0.2% +$14.7K 0.99% 22
2014
Q2
$6.67M Buy
80,404
+19
+0% +$1.48K 0.75% 34
2014
Q1
$5.7M Buy
80,385
+3,361
+4% +$264K 0.67% 47
2013
Q4
$5.78M Sell
77,024
-2,332
-3% -$162K 0.7% 45
2013
Q3
$4.99M Sell
79,356
-1,077
-1% -$64.4K 0.67% 47
2013
Q2
$4.12M Buy
+80,433
New +$4.19M 0.59% 51

Other funds holding GILD

WhitTier Trust Company's GILD Position: Q2 2026 in Review

WhitTier Trust Company reduced its Gilead Sciences (GILD) stake by 5.7% in Q2 2026, selling an estimated $249K and leaving 31,384 shares worth $4.28M. The position accounts for 0.08% of the portfolio, ranked #177.

WhitTier Trust Company first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.81M in Q2 2015. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WhitTier Trust Company held 31,384 shares of Gilead Sciences worth $4.28M as of Q2 2026.
  • WhitTier Trust Company sold 1,887 Gilead Sciences shares in Q2 2026, an estimated $249K.
  • Gilead Sciences made up 0.08% of WhitTier Trust Company's portfolio in Q2 2026, its #177 holding.
  • WhitTier Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's Gilead Sciences position peaked at $8.81M in Q2 2015.
  • 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.